Systems medicine research network for the early detection and prevention of #livercancer #fattyliver #BMFTR
Joined November 2022
- Tweets301
- Following234
- Followers109
- Likes794
LiSyM-Cancer retweeted
Seven women. Seven careers. Seven pieces of advice.
For #InternationalDayOfWomenAndGirlsInScience we’re celebrating the voices and wisdom of women shaping science and technology across Europe. #IDWGS #WomenInSTEM
🔗esa.int/About_Us/Diversity_a…
@Soph_astro @CERN @ESO @embl @EuropeanXFEL @EIROforum
LiSyM-Cancer retweeted
Ever wondered which method to use to infer kinase activities from phosphoproteomics data? 💻💭Our revised comprehensive evaluation of kinase activity inference tools, done in collaboration with the Zhang lab @bcmhouston, is now out @NatureComms 🔬 tinyurl.com/4twuc6z4
LiSyM-Cancer retweeted
The team of @JonelTrebicka and colleagues have published the CLIF-SIG score that allows accurate estimation of systemic #inflammation and prognosis in patients with acutely decompensated #cirrhosis.
@ef_clif @UK_Muenster
gut.bmj.com/content/early/20… – at Münster, Germany
LiSyM-Cancer retweeted
🧪We are now calling for late-breaker abstracts for #EASLCongress 2025.
Take this unique opportunity to showcase your research, connect with the global liver health community, and shape the future of hepatology.
Submission deadline: 17 March 2025
Be part of the conversation—submit today!
📎easlcongress.eu/2025-abstrac…
@AleksanderKrag @DebbieShawcros1 @RuiCastroHD @FrancqueSven @analleo @fprusso73 @aelsharkawy75 @PinterMatthias @bogdanprocopet
LiSyM-Cancer retweeted
Möchten Sie Ihr Know-how zu den neuesten Entwicklungen in Genomics, Datenschutz, Datenqualität, Sekundärdatennutzung oder KI in der Forschung erweitern? Dann seien Sie bei den TMF-Tutorials 2025 dabei!
📅 Wann? 1.4.2025
📍 Wo? Freiburg
➡️ Infos: tinyurl.com/muwzywur
LiSyM-Cancer retweeted
The #EASLCongress 2025 is your chance to engage with cutting-edge science, hands-on training, and world-class experts in hepatology!
Taking place on 7–10 May in Amsterdam & online, this year’s congress is designed to be an immersive and dynamic experience, equipping you with the latest knowledge and practical skills to advance patient care.
🤩Have you registered? easlcongress.eu/2025-registr…
📄Explore our diverse scientific programme: easlcongress.eu/2025-scienti…
🔬STATE-OF-THE-ART – Stay ahead of the curve with renowned experts presenting the latest breakthroughs shaping hepatology.
💁MEET-THE-EXPERTS – Get up close with key opinion leaders in an informal setting to discuss specialised topics.
🔃SKILLS LEARNING CENTRES – Take part in hands-on sessions to refine your practical skills and gain real-world expertise.
🚀FUTURE OF HEPATOLOGY – Explore the next frontier with discussions on telemedicine, AI, and the evolution of liver care.
....and much more! Secure your spot!
LiSyM-Cancer retweeted
Make sure to join us next week for an #EASLStudio @JHepatology Live!
👉EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?
📅 Wednesday 12 February ¦ 18:00 CET
🔗 easl.eu/easl-studio-episode/…
@EASLNews @AleksanderKrag @FrancqueSven @DebbieShawcros1 @aelsharkawy75 @Rabataller @ThomasBerg24 @LorenzaRimassa @ProfPaoloAngeli
#LiverX #LiverTwitter #HCC
LiSyM-Cancer retweeted
❄️Winter magic in our hometown of #Dresden! The famous Dresdner #Christmas Market known since 1434 is the oldest in Germany. Feel privileged to live and do science touching history here. ♥️Happy to share this charming time with you!
striezelmarkt.dresden.de/
#phdlife #phdchat
LiSyM-Cancer retweeted
📢Two weeks left! 15 flash talks, all around #omics and #massspec on our traditional
VII XMass Updates symposium
Dec 3rd 2024 2-5pm CET, Dresden
❗️Talks will be also live streamed via Zoom
No registration required
Info: tinyurl.com/MSDRESDEN
LiSyM-Cancer retweeted
We're very excited to be chatting with Dr. Meritxell Huch (@MeriHuchLab) next week!
Check out her lab's @NatureComms article on #hepatocyte regeneration and #LiverCancer: go.nature.com/40oQbRU
LiSyM-Cancer retweeted
October is #LiverCancerAwarenessMonth!
What can we do to reduce the risks of #LiverCancer? Vaccinating against #hepatitisB, treating #hepatitisC, limiting alcohol & tobacco consumption, and maintaining a healthy weight are all important!
bit.ly/3vTyJFt
@dice_europe
LiSyM-Cancer retweeted
Ever wondered which method to use to infer kinase activities from phosphoproteomics data? 💻💭In collaboration with the Zhang lab @bcmhouston, we performed a comprehensive evaluation of kinase activity inference tools to help answer that question tinyurl.com/yc56axsv 🧵⬇️
LiSyM-Cancer retweeted
On Thursday, I'll give a webinar on the wedding between machine learning and deterministic modelling 🤓
🎬 glimprint.org/lorenz-adlung-…
LiSyM-Cancer retweeted
We are hiring! If you are a Research Software Engineer with experience in Python + database & modernising
@omnipathdb using biocypher.org/ sounds interesting to you, please apply
This Post is from an account that no longer exists. Learn more
LiSyM-Cancer retweeted
Do you want to pursue your ideas in computational biology independently, running your group in @embl ‘s uniquely collaborative environment, next to world’s most comprehensive molecular data resources + with top-notch infrastructure @emblebi? Apply to join us & pls RT
Apply as a research group leader! Lead an independent research group in computational biology, focusing on AI-biology interfaces. Enjoy core support and outstanding infrastructure. Explore EMBL's Molecules to Ecosystems vision, and more!
embl.org/jobs/position/EBI02…
LiSyM-Cancer retweeted
🔬 We were excited to share our latest research on the PLEASE score and the DETECT trial at #SBMC2024! 🌟 Joining us for discussions, idea exchange, and networking was truly fulfilling.
@LiSyMCancer @BMBF_Bund @R_Schierwagen @JonelTrebicka
LiSyM-Cancer retweeted
Screening for #HCC in cirrhosis? Yes! It offers survival benefits. But there's room for improvement! Let's implement more accessible surveillance tools. #LiverCancer doi:10.1001/jamanetworkopen.2024.8755
@docamitgs #livertwitter, #EASLnews @EuropeLiver @AleksanderKrag
LiSyM-Cancer retweeted
Our research group that is currently split between Halle and Tübingen gathers to join the 9th conference on Systems Biology of Mammalian Cells #SBMC2024 at the University of Leipzig where we present and discuss our research on constraint-based modeling with international experts.
ALT The data analytics and bioinformatics team gathered in Leipzig at the 9th conference on Systems Biology of Mammalian Cells (SBMC). From left to right: Andreas Dräger, Gwendolyn O. Döbel, Carolin Brune, and Nantia Leonidou.
LiSyM-Cancer retweeted
Interesting discussions on the benefits of interdisciplinary research for advancing science, how to make it work &what are the challenges when bringing different fields/people together #sbmc2024 #systemsbiology #systemsmedicine @LiSyMCancer
